45 days later, BioCryst abandons another program, citing stiff competition

Submitted by admin on December 15, 2022 - 11:07am

Source:

Fierce Biotech

News Tags:

Biocryst

ASH 2022

BCX9930

Headline:

45 days later, BioCryst abandons another program, citing stiff competition

snippet:

Last month, BioCryst trimmed down its pipeline to two drugs in complement-mediated diseases: BCX9930 and BCX10013. Fast-forward 45 days and BCX9930 is headed to the garbage can, too.

Search form

You are here

45 days later, BioCryst abandons another program, citing stiff competition

45 days later, BioCryst abandons another program, citing stiff competition